Histamine and migraine revisited: mechanisms and possible drug targets
Abstract Objective To review the existing literature on histamine and migraine with a focus on the molecule, its receptors, its use in inducing migraine, and antihistamines in the treatment of migraine. Background Histamine has been known to cause a vascular type headache for almost a hundred years....
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2019-03-01
|
| Series: | The Journal of Headache and Pain |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s10194-019-0984-1 |
| _version_ | 1828499431595442176 |
|---|---|
| author | Jacob Worm Katrine Falkenberg Jes Olesen |
| author_facet | Jacob Worm Katrine Falkenberg Jes Olesen |
| author_sort | Jacob Worm |
| collection | DOAJ |
| description | Abstract Objective To review the existing literature on histamine and migraine with a focus on the molecule, its receptors, its use in inducing migraine, and antihistamines in the treatment of migraine. Background Histamine has been known to cause a vascular type headache for almost a hundred years. Research has focused on antihistamines as a possible treatment and histamine as a migraine provoking agent but there has been little interest in this field for the last 25 years. In recent years two additional histamine (H3 and H4) receptors have been discovered and a series of non-sedating antihistamines have been developed. It is therefore timely to review the field again. Methods For this review the PubMed/MEDLINE database was searched for eligible studies. We searched carefully for all articles on histamine, antihistamines and histamine receptors in relation to migraine and the nervous system. The following search terms were used: histamine, migraine disorders, migraine, headache, antihistamines, histamine antagonists, clinical trials, induced headache, histamine H3 receptor, histamine H4 receptor and pharmacology. Four hundred thirty-six titles were read, 135 abstracts were read, 112 articles were read in full and 53 articles were used in this review. Review process resulted in 12 articles added to a total of 65. Findings Early studies of H1 and H2 antihistamines lack scientific strength and show conflicting results. Most of the antihistaminic drugs used in these trials bind also to other receptors which makes it difficult to conclude on the antihistaminic effect. Histamine is an efficient inducer of migraine attacks in migraine patients by an H1 mechanism most likely extracerebrally. These findings merit further investigation of antihistamines in clinical drug trials. The H3 and H4 receptors are found in primarily in CNS and immune tissues, respectively. H3 is likely to be involved in antinociception and has been linked with cognitive, neurodegenerative and sleep disorders. The only marketed H3 agent, pitolisant, is a brain penetrant H3 antagonist/inverse agonist which increases central histamine and causes headache. The experimental H3 agonist Nα-methylhistamine has shown promising results as a migraine preventative in studies of uncertain quality. With the current limited knowledge of the H4 receptor it is questionable whether or not the receptor is involved in migraine. Conclusion There is insufficient support for first generation antihistamines (both H1 and H2) as preventive migraine medications and sedation and weight gain are unacceptable side effects. Non-sedating H1 antihistamines need to be appropriately tested. Central H3 receptors seem to have a role in migraine that merit further investigation. The histaminergic system may be a goal for novel migraine drugs. |
| first_indexed | 2024-12-11T13:24:29Z |
| format | Article |
| id | doaj.art-f833035845094ac8937443aa7016f254 |
| institution | Directory Open Access Journal |
| issn | 1129-2369 1129-2377 |
| language | English |
| last_indexed | 2024-12-11T13:24:29Z |
| publishDate | 2019-03-01 |
| publisher | BMC |
| record_format | Article |
| series | The Journal of Headache and Pain |
| spelling | doaj.art-f833035845094ac8937443aa7016f2542022-12-22T01:05:39ZengBMCThe Journal of Headache and Pain1129-23691129-23772019-03-0120111210.1186/s10194-019-0984-1Histamine and migraine revisited: mechanisms and possible drug targetsJacob Worm0Katrine Falkenberg1Jes Olesen2Danish Headache Center and Department of Neurology N39, University of CopenhagenDanish Headache Center and Department of Neurology N39, University of CopenhagenDanish Headache Center and Department of Neurology N39, University of CopenhagenAbstract Objective To review the existing literature on histamine and migraine with a focus on the molecule, its receptors, its use in inducing migraine, and antihistamines in the treatment of migraine. Background Histamine has been known to cause a vascular type headache for almost a hundred years. Research has focused on antihistamines as a possible treatment and histamine as a migraine provoking agent but there has been little interest in this field for the last 25 years. In recent years two additional histamine (H3 and H4) receptors have been discovered and a series of non-sedating antihistamines have been developed. It is therefore timely to review the field again. Methods For this review the PubMed/MEDLINE database was searched for eligible studies. We searched carefully for all articles on histamine, antihistamines and histamine receptors in relation to migraine and the nervous system. The following search terms were used: histamine, migraine disorders, migraine, headache, antihistamines, histamine antagonists, clinical trials, induced headache, histamine H3 receptor, histamine H4 receptor and pharmacology. Four hundred thirty-six titles were read, 135 abstracts were read, 112 articles were read in full and 53 articles were used in this review. Review process resulted in 12 articles added to a total of 65. Findings Early studies of H1 and H2 antihistamines lack scientific strength and show conflicting results. Most of the antihistaminic drugs used in these trials bind also to other receptors which makes it difficult to conclude on the antihistaminic effect. Histamine is an efficient inducer of migraine attacks in migraine patients by an H1 mechanism most likely extracerebrally. These findings merit further investigation of antihistamines in clinical drug trials. The H3 and H4 receptors are found in primarily in CNS and immune tissues, respectively. H3 is likely to be involved in antinociception and has been linked with cognitive, neurodegenerative and sleep disorders. The only marketed H3 agent, pitolisant, is a brain penetrant H3 antagonist/inverse agonist which increases central histamine and causes headache. The experimental H3 agonist Nα-methylhistamine has shown promising results as a migraine preventative in studies of uncertain quality. With the current limited knowledge of the H4 receptor it is questionable whether or not the receptor is involved in migraine. Conclusion There is insufficient support for first generation antihistamines (both H1 and H2) as preventive migraine medications and sedation and weight gain are unacceptable side effects. Non-sedating H1 antihistamines need to be appropriately tested. Central H3 receptors seem to have a role in migraine that merit further investigation. The histaminergic system may be a goal for novel migraine drugs.http://link.springer.com/article/10.1186/s10194-019-0984-1MigraineHistamineAntihistaminesHistamine receptorsDrug targets |
| spellingShingle | Jacob Worm Katrine Falkenberg Jes Olesen Histamine and migraine revisited: mechanisms and possible drug targets The Journal of Headache and Pain Migraine Histamine Antihistamines Histamine receptors Drug targets |
| title | Histamine and migraine revisited: mechanisms and possible drug targets |
| title_full | Histamine and migraine revisited: mechanisms and possible drug targets |
| title_fullStr | Histamine and migraine revisited: mechanisms and possible drug targets |
| title_full_unstemmed | Histamine and migraine revisited: mechanisms and possible drug targets |
| title_short | Histamine and migraine revisited: mechanisms and possible drug targets |
| title_sort | histamine and migraine revisited mechanisms and possible drug targets |
| topic | Migraine Histamine Antihistamines Histamine receptors Drug targets |
| url | http://link.springer.com/article/10.1186/s10194-019-0984-1 |
| work_keys_str_mv | AT jacobworm histamineandmigrainerevisitedmechanismsandpossibledrugtargets AT katrinefalkenberg histamineandmigrainerevisitedmechanismsandpossibledrugtargets AT jesolesen histamineandmigrainerevisitedmechanismsandpossibledrugtargets |